JO
CDTX

John Overdeck’s Cidara Therapeutics CDTX Stock Holding History

John Overdeck’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,362
Closed -$61.9K – 3060
2024
Q1 		$61.9K Buy
+3,362
New +$48.3K ﹤0.01% 2872
2023
Q4 		– Sell
-2,805
Closed -$52.9K – 3171
2023
Q3 		$52.9K Sell
2,805
-8,356
-75% -$164K ﹤0.01% 2809
2023
Q2 		$252K Buy
11,161
+4,486
+67% +$105K ﹤0.01% 2569
2023
Q1 		$170K Buy
+6,675
New +$189K ﹤0.01% 2591
2022
Q2 		– Sell
-1,027
Closed -$17K – 2558
2022
Q1 		$17K Sell
1,027
-11,790
-92% -$200K ﹤0.01% 2530
2021
Q4 		$326K Sell
12,817
-5,850
-31% -$182K ﹤0.01% 3583
2021
Q3 		$836K Buy
18,667
+15,887
+571% +$604K ﹤0.01% 2776
2021
Q2 		$112K Sell
2,780
-7,028
-72% -$297K ﹤0.01% 3884
2021
Q1 		$522K Buy
9,808
+6,321
+181% +$312K ﹤0.01% 2887
2020
Q4 		$139K Buy
3,487
+276
+9% +$13.7K ﹤0.01% 3173
2020
Q3 		$183K Sell
3,211
-8,272
-72% -$584K ﹤0.01% 2842
2020
Q2 		$847K Buy
11,483
+4,323
+60% +$280K ﹤0.01% 1640
2020
Q1 		$355K Buy
7,160
+3,816
+114% +$229K ﹤0.01% 2181
2019
Q4 		$257K Buy
+3,344
New +$153K ﹤0.01% 3292
2019
Q2 		– Sell
-840
Closed -$45K – 3346
2019
Q1 		$45K Sell
840
-627
-43% -$34.4K ﹤0.01% 2941
2018
Q4 		$69K Buy
1,467
+721
+97% +$51.5K ﹤0.01% 2846
2018
Q3 		$66K Buy
+746
New +$65.8K ﹤0.01% 3093

Other funds holding CDTX

MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $390M AUM 96.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

John Overdeck's CDTX Position: Q2 2024 in Review

John Overdeck sold out of Cidara Therapeutics (CDTX) in Q2 2024, closing a stake of 3,362 shares — an estimated $61.9K sold.

John Overdeck first reported a position in CDTX in Q3 2018 and held it in 17 quarters. The position peaked at $847K in Q2 2020. 26 funds tracked by Wall St. Rank hold CDTX as of Q2 2024.

  • John Overdeck reported no remaining Cidara Therapeutics position as of Q2 2024 after selling out during the quarter.
  • John Overdeck sold 3,362 Cidara Therapeutics shares in Q2 2024, an estimated $61.9K.
  • John Overdeck first reported a position in Cidara Therapeutics in Q3 2018 and held it in 17 quarters.
  • John Overdeck's Cidara Therapeutics position peaked at $847K in Q2 2020.
  • 26 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q2 2024.

Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.